Synthesis and Spin-Trapping Chemistry of 5,5-Dimethyl-2-(trifluoromethyl)-1-pyrroline N-Oxide
摘要:
A new five-membered ring nitrone, 5,5-dimethyl-2-(trifluoromethyl)-1-pyrroline N-oxide (2-TFDMPO), is synthesized for the purpose of spin trapping in free radical biology. Most of the spin adducts of 2-TFDMPO are persistent, and EPR, ENDOR, and MS spectra can be obtained. A variety of radicals give characteristic spectral signatures, among which is a rare type of line width alternation pattern due to hindered rotation of the trifluoromethyl group.
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF
申请人:FUJIFILM Corporation
公开号:US20150322063A1
公开(公告)日:2015-11-12
A compound represented by Formula [1] (in the formula, Z
1
represents N, CH, or the like; X
1
represents NH or the like; R
1
represents a heteroaryl group or the like; each of R
2
, R
3
, and R
4
represents a hydrogen atom, a halogen atom, an alkoxy group, or the like; and R
5
represents a heteroaryl group or the like) or salt thereof.
The present invention relates to compounds of formula I
wherein A, G, r and R
1
to R
5
are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
The synthesis of trifluoromethylvinylketone is described. The metal hydride reduction of ethyl trifluoroacetoacetate gives the glycol . Selective tosylation of occurs on the primary hydroxyl group and leads to . Tosyl-chloride exchange produces the chlorohydrin which is oxydized to the β chloroketone . The dehydrohalogenation of leads to the fluorinated ethylenic ketone .
The role of remotely located ammonium groups in the active site of many phosphate-cleaving enzymes is investigated by using model systems thus providing mechanistic hints to a still unsolved problem.
Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
申请人:——
公开号:US20040220234A1
公开(公告)日:2004-11-04
There are provided novel compounds of formula (I) [Chemical formula should be inserted here. Please see paper copy] wherein R
1
, R
2
, R
3
, T, U, X, Y, V and W are as defined in the specification, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease, CNS disorders and pain.